Hugo Norlén
Advokatfirman Lindahl KBAdvokatfirman Lindahl KB houses a group known for its ‘strong and deep’ knowledge of the sector, regularly assisting start-ups and venture capital backed companies, in addition to international players in the pharma industry. Praised for his ‘excellent’ industry knowledge, Hugo Norlén leads the Uppsala-based team with his longstanding expertise in strategic collaborations and technology transfers within the pharma, medtech and biotech spaces. Gunnar Mattsson is noted for his broad expertise in corporate and international contractual matters, acting for a number of public and private life sciences companies, while Mikael Smedeby regularly handles issues concerning M&A and licensing transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Really client centered - always there when you need them, and rallies to bring the best team together depending on the area of expertise needed in each case. Strong and deep knowledge in the field of life sciences, makes a difference to work with an industry expert compared to a generalist.’
‘Down to earth, committed to the client, fast, problem-solving approach. Hugo Norlén has excellent industry knowledge and is really service-minded. He's also really good at bringing in other parts of the team, when other expertise is needed.’
‘Good background knowledge and understanding of our business model, and the dynamics of the pharma industry in general. Pragmatic approach with valuable sharing of creative ideas to overcome roadblocks in negotiations. Very committed team, responsive and available when needed.’
‘Experienced and qualified team that are able to give proper attention on short notice.’
- ‘It is comparatively easy to always propose the legal high ground where the client has the upper hand on all contractual matters. All negotiations are based on compromise, the ability to separate and navigate the difference between must haves and give aways is the key to solid legal advice. The Lindahl team is very strong in this respect.’
‘Great industry knowledge, clear and pragmatic advice.’
Key clients
- Affibody AB
- Philips AB, Personal Heath
- BioArctic AB
- Palette Life Sciences AB
- ThermoFisher Scientific/Phadia AB
- Q-linea AB
- Orexo AB
- Senzime AB
- Egetis Therapeutics AB
- Eurocine Vaccines AB
- Nanologica AB
- Ilya Pharma AB
- Vitrolife AB
- Redwood Pharma AB
- AMRA Medical AB
- Dilafor AB
- Nanexa AB
- Intrance Medical Systems Inc
- NeoDynamics AB
- Miris AB
- Stardots AB
- BioLamina AB
- Navinci Diagnostics AB
- Salipro Biotech AB
Work highlights
- Advised Palette Life Sciences on Teleflex’s $650m acquisition of the company.
- Advised Corline Biomedical on a license agreement with the California-based company Imperative Care, with a total deal value of SEK1bn (approx. $90m).
- Advised Ziccum in connection with a fully funded evaluation agreement with an international biopharmaceutical corporation focused on mRNA technologies.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Hugo Norlén